Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.

[1]  D. Cole,et al.  Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study. , 2000, Archives of internal medicine.

[2]  M. Monden,et al.  Common C677T polymorphism in the methylenetetrahydrofolate reductase gene increases the risk for deep vein thrombosis in patients with predisposition of thrombophilia. , 2000, Thrombosis research.

[3]  H. Hsu,et al.  Causes of venous thrombosis in fifty Chinese patients , 2000, American journal of hematology.

[4]  M. Shen,et al.  The prevalence of C677T mutation in the methylenetetrahydrofolate reductase gene and its association with venous thrombophilia in Taiwanese Chinese. , 2000, Thrombosis research.

[5]  A. M. Leone,et al.  Prevalence of mild hyperhomocysteinaemia and association with thrombophilic genotypes (factor V Leiden and prothrombin G20210A) in Italian patients with venous thromboembolic disease , 1999, British journal of haematology.

[6]  M. Gaustadnes,et al.  Thrombophilic predisposition in stroke and venous thromboembolism in Danish patients. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[7]  R. Saxena,et al.  Pathogenetic factors underlying juvenile deep vein thrombosis (DVT) in Indians , 1999, European journal of haematology.

[8]  D. Steinberg,et al.  Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[9]  S. Eichinger,et al.  No evidence for an increased risk of venous thrombosis in patients with factor V Leiden by the homozygous 677 C to T mutation in the methylenetetrahydrofolate-reductase gene. , 1999, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[10]  H. Blom,et al.  Hyperhomocysteinemia and Venous Thrombosis: A Meta-analysis , 1998, Thrombosis and Haemostasis.

[11]  S. Eichinger,et al.  Hyperhomocysteinemia Is a Risk Factor of Recurrent Venous Thromboembolism , 1998, Thrombosis and Haemostasis.

[12]  R. Hull,et al.  1 Thrombophilia: disorders predisposing to venous thromboembolism , 1998 .

[13]  M. Margaglione,et al.  The Methylenetetrahydrofolate Reductase TT677 Genotype Is Associated with Venous Thrombosis Independently of the Coexistence of the FV Leiden and the Prothrombin , 1998, Thrombosis and Haemostasis.

[14]  P. Reitsma,et al.  Thermolabile Methylenetetrahydrofolate Reductase and Factor V Leiden in the Risk of Deep-Vein Thrombosis , 1998, Thrombosis and Haemostasis.

[15]  P. Mannucci,et al.  A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q506). , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[16]  W. Tsay,et al.  High prevalence of antithrombin III, protein C and protein S deficiency, but no factor V Leiden mutation in venous thrombophilic Chinese patients in Taiwan. , 1997, Thrombosis research.

[17]  J. Witteman,et al.  Plasma total homocysteine, B vitamins, and risk of coronary atherosclerosis. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[18]  F. Costa,et al.  The Mutation Ala677→Val in the Methylene Tetrahydrofolate Reductase Gene: A Risk Factor for Arterial Disease and Venous Thrombosis , 1997, Thrombosis and Haemostasis.

[19]  P. Mannucci,et al.  Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism. , 1997, Circulation.

[20]  J. Fontcuberta,et al.  Laboratory Evaluation and Clinical Characteristics of 2,132 Consecutive Unselected Patients with Venous Thromboembolism – Results of the Spanish Multicentric Study on Thrombophilia (EMET*-Study) , 1997, Thrombosis and Haemostasis.

[21]  I. Rosenberg,et al.  Plasma homocysteine as a risk factor for atherothrombotic events in systemic lupus erythematosus , 1996, The Lancet.

[22]  Y. Ko,et al.  The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individuals , 1996, Human Genetics.

[23]  K. Mccully.  Homocysteine and vascular disease , 1996, Nature Medicine.

[24]  P. Reitsma,et al.  Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. , 1996, The New England journal of medicine.

[25]  G. Omenn,et al.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes. , 1995, JAMA.

[26]  P. Ueland,et al.  Plasma homocysteine levels in patients with deep venous thrombosis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[27]  P. Reitsma,et al.  Protein C deficiency in a controlled series of unselected outpatients: an infrequent but clear risk factor for venous thrombosis (Leiden Thrombophilia Study) , 1995, Blood.

[28]  H. Blom,et al.  Is hyperhomocysteinaemia a risk factor for recurrent venous thrombosis? , 1995, The Lancet.

[29]  P. Ridker,et al.  Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. , 1995, The New England journal of medicine.

[30]  P. Mannucci,et al.  High prevalence of hyperhomocyst(e)inemia in patients with juvenile venous thrombosis. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

[31]  P. Wilson,et al.  Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. , 1993, JAMA.

[32]  H. Büller,et al.  Deficiencies of coagulation-inhibiting and fibrinolytic proteins in outpatients with deep-vein thrombosis. , 1990, The New England journal of medicine.

[33]  S. S. Kang,et al.  Intermediate homocysteinemia: a thermolabile variant of methylenetetrahydrofolate reductase. , 1988, American journal of human genetics.

[34]  D. Wilcken,et al.  The pathogenesis of coronary artery disease. A possible role for methionine metabolism. , 1976, The Journal of clinical investigation.

[35]  K. Mccully.  Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. , 1969, The American journal of pathology.

[36]  B. Dahlbäck,et al.  Thrombophilia as a multigenic disease. , 1999, Haematologica.

[37]  G Leone,et al.  Epidemiology of Factor V Leiden: Clinical Implications , 1998, Seminars in thrombosis and hemostasis.

[38]  R. Matthews,et al.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase , 1995, Nature Genetics.

[39]  P. Kyrle,et al.  Anticardiolipin antibodies in patients with venous thrombosis. , 1991, Haemostasis.

[40]  L. Taylor,et al.  The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. , 1991, Journal of vascular surgery.